Navigation Links
Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
Date:9/5/2008

nd have the potential to form the basis for a new class of diagnostics and therapeutics. MicroRNAs have been shown to have different expression profiles in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The first test based on the company's technology, differentiating squamous from non squamous non small cell lung cancer, is now approved through Columbia University Medical Center's High Complexity Molecular Pathology Laboratory. In Addition, the company expects two additional microRNA diagnostic tests applying its technology will be validated and submitted for regulatory approval by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the potential of microRNAs extracted from blood to serve as effective biomarkers for a wide range of indications, including colon cancer, the role of microRNAs in human physiology and disease, the potential of microRNAs in
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
2. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
3. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
4. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
5. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
6. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
8. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
9. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: ... program encouraging health professionals to help maintain the ... on long-term androgen deprivation therapy (ADT). Nearly ... treatment for prostate cancer that, while highly effective ... loss and increase a man,s risk for osteoporosis. ...
(Date:12/14/2009)... Ohr Pharmaceutical Inc. (OTC Bulletin Board: OHRP) ... Inc, headquartered in Irvine, CA, with offices also ... for investor relations and corporate communications. Ohr ... on developing advanced drugs for underserved therapeutic needs. ... large, global markets: OHR/AVR118 for the treatment of ...
(Date:12/14/2009)... Calif. and REHOVOT, Israel, Dec. 14 ... technology and services resource for pathologists, oncologists and ... today jointly announced that they will collaborate on ... non-invasive test for the early detection of non-small ... patient,s sputum and was originally developed at the ...
Breaking Medicine Technology:Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 2Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 4New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 1New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 2New Online Tutorials for Madeline 2 0 and CGAP from OpenHelix 54603 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 1AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 2AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 3AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 4AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 5AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 6AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 7US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7
... Mass., April 3, 2008 Thermo Fisher,Scientific Inc. ... serving science, announced,that it has received U.S. Food ... test designed to screen for methicillin-resistant,Staphylococcus aureus (MRSA), ... Positive Predictive Value commercially available for MRSA,screening, Spectra ...
... N.J., April 3, 2008 Medarex, Inc.,(Nasdaq: ... statement in response to the,announcement by Pfizer ... 3 clinical,trial of front-line treatment with Pfizer,s ... patients with advanced,melanoma. Dr. Geoffrey M. Nichol, ...
Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4Medarex Announces Ipilimumab Program Continues to Move Forward 2Medarex Announces Ipilimumab Program Continues to Move Forward 3Medarex Announces Ipilimumab Program Continues to Move Forward 4Medarex Announces Ipilimumab Program Continues to Move Forward 5
(Date:12/14/2009)... may also offer some protection, study finds, , , MONDAY, ... people who can,t start their morning without a cup ... decrease the risk of developing type 2 diabetes. ... also found the more coffee you drink, the lower ... associated with a 7 percent reduction in the risk ...
(Date:12/14/2009)... for asthma, COPD, researchers say , , MONDAY, Dec. 14 ... that influence lung function, a finding that may help ... international team of researchers compared lung function with genetic ... the human genome in more than 20,000 people of ... common genetic variants associated with alterations in lung function. ...
(Date:12/14/2009)... United Nations Foundation’s Nothing But Nets tipped off a promotion--Send a ... anti-malaria bed nets to refugees in 11 African countries. The effort ... through January 31, 2010. , ... New ... Association (NBA) and the United Nations Foundation’s Nothing But Nets tipped ...
(Date:12/14/2009)... Hospital records show consistent rate of lacerations, accidental ... ,, BOSTON, Dec. 14 A new ... Medicine has found that holiday decorations, particularly glass ... consider during the season. A review of records ... five ornament-related injuries per year, more than half ...
(Date:12/14/2009)... asked to approve naming the women,s hospital -- located ... complex -- after Ted and Jane Von Voigtlander ... University of Michigan Health System has received a $15 ... Foundation, the largest gift ever made to the Health ... of a new women,s hospital. ,, The gift is ...
Breaking Medicine News(10 mins):Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5
... MDThe United States places last among 19 countries when it ... to timely and effective health care, according to new research ... issue of Health Affairs. While other nations dramatically improved these ... , If the U.S. had performed as well as the ...
... have found that Medicare spending across the country varies greatly. ... be the same no matter which region a person lives ... there is no value to the excess costs in high-spending ... cancer as a model suggests this is not correct. ...
... Ill., Jan. 7 When it comes to graduate ... of Nursing in,Peoria sets the pace for others in ... to offer a Doctorate of Nursing Practice (DNP) Program,in ... the only,joint degree -- Master,s in Nursing and Master,s ...
... 7 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ... fourth quarter and full-year 2007 sales and earnings conference,call ... January 29, 2008,at 8:00 a.m. Eastern Time. A news ... available at 7:00 a.m. the morning of the,conference call., ...
... Congress to allow price,negotiation, WASHINGTON, Jan. 7 ... plans continue to hike the cost of,prescriptions for seniors, ... drugs, between the month of December and January alone. ... five drugs by more than,$500 during that time., ...
... a New Department Designed to Establish Manufacturer Advertising through the ... ... Pharmacy., TALLAHASSEE, Fla., Jan. 7 Deborah Faucette, R.Ph. has,been named ... Sales and Marketing., Deb will lead a new department that, according ...
Other Medicine News:Health News:New study: US ranks last among other industrialized nations on preventable deaths 2Health News:Higher Medicare spending yields mixed bag for patients 2Health News:Higher Medicare spending yields mixed bag for patients 3Health News:UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice 2Health News:UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice 3Health News:Most Medicare Drug Plans Continue to Hike Costs into 2008 Two-to-Three Times Rate of Inflation 2Health News:Most Medicare Drug Plans Continue to Hike Costs into 2008 Two-to-Three Times Rate of Inflation 3Health News:LearnSomething Names Deborah Faucette to New Position of Senior Vice President of Sales and Marketing 2Health News:LearnSomething Names Deborah Faucette to New Position of Senior Vice President of Sales and Marketing 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: